Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
Authors:
Open Access
- 4 August 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Abstract
Background: Clostridioides difficile(C. difficile) is one of the primary pathogens responsible for infectious diarrhea. Antibiotic treatment failure, occurring in about 30% of patients, and elevated rates of antibiotic resistance pose a major challenge for therapy. Reinfection often occurs by isolates that produce biofilm, a protective barrier impermeable to antibiotics. We explored the association between antibiotic resistance (in planktonic form) and biofilm-production in 123 C. difficileclinical isolates.Results: Overall, 66 (53.6%) out of 123 isolates produced a biofilm, with most of them being either a strong (44%) or moderate (34.8%) biofilm producers. When compared to susceptible isolates, a statistically higher percentage of isolates with reduced susceptibility to metronidazole or vancomycin were biofilm producers (p< 0.0001, for both antibiotics). Biofilm production intensity was higher among tolerant isolates; 53.1% of the metronidazole-susceptible isolates were not able to produce biofilms, and only 12.5% were strong biofilm-producers. In contrast, 63% of the isolates with reduced susceptibility had a strong biofilm-production capability, while 22.2% were non-producers. Among the vancomycin-susceptible isolates, 51% were unable to produce biofilms, while all the isolates with reduced vancomycin susceptibility were biofilm-producers. Additionally, strong biofilm production capacity was more common among the isolates with reduced vancomycin susceptibility, compared to susceptible isolates (72.7%vs.18.8%, respectively). The distribution of biofilm capacity groups was statistically different between different Sequence-types (ST) strains (p=0.001). For example, while most of ST2 (66.7%), ST13 (60%), ST42 (80%) isolates were non-producers, most (75%) ST6 isolates were moderate producers and most of ST104 (57.1%) were strong producers.Conclusions: Our results suggest an association between reduced antibiotic susceptibility and biofilm production capacity. This finding reinforces the importance of antibiotic susceptibility testing, mainly in recurrence infections that may be induced by a strain that is both antibiotic tolerant and biofilm producer. Better adjustment of treatment in such cases may reduce recurrences rates and complications. The link of biofilm production and ST should be further validated; if ST can indicate on isolate virulence, then in the future, when strain typing methods will be more available to laboratories, ST determination may aid in indecision between supportivevs.aggressive treatment.Keywords
This publication has 54 references indexed in Scilit:
- Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0APLOS ONE, 2012
- Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or VancomycinClinical Infectious Diseases, 2012
- Biofilm-growing intestinal anaerobic bacteriaFEMS Immunology & Medical Microbiology, 2012
- Macro and Micro Diversity of Clostridium difficile Isolates from Diverse Sources and Geographical LocationsPLOS ONE, 2012
- Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291Journal of Medical Microbiology, 2011
- Multilocus Sequence Typing of Clostridium difficileJournal of Clinical Microbiology, 2010
- Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised HostsInfection and Immunity, 2009
- Synergistic Effects in Mixed Escherichia coli Biofilms: Conjugative Plasmid Transfer Drives Biofilm ExpansionJournal of Bacteriology, 2006
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Natural conjugative plasmids induce bacterial biofilm developmentNature, 2001